Skip to main content

AtonRa Partners

SEC CIK
0001846445
Latest filing
Feb 5, 2024

ICPT holding history

Intercept Pharmaceuticals, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ICPT overviewAll 13F holders of ICPTFull Q4 2023 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
5
Since Q2 2022
Holdings of ICPT by AtonRa Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−18,581−100.0%Sold outHolders
Q2 202318,581$205.5K0.3%−1,251−6.3%ReducedHolders
Q1 202319,832$266.3K0.4%−1,932−8.9%ReducedHolders
Q4 202221,764$269.2K0.3%−5,886−21.3%ReducedHolders
Q3 202227,650$386.0K0.4%+3,233+13.2%AddedHolders
Q2 202224,417$337.0K0.3%+24,417NewHolders